AWAKN LIFE SCIENCES LISTS ON THE NEO EXCHANGE
Today, Canadian-based biotechnology company Awakn Life Sciences began trading on the NEO Exchange under the symbol AWKN.
The company’s focus is the treatment of addiction with psychedelic drugs, therapies and technologies, in the pursuit of providing hope for people for whom the current treatment methodologies are not working, CEO Anthony Tennyson told PSYCH following the company’s debut on the exchange.
‘That requires big money, and that’s what the capital market strategy is all about. Yes, it’s about creating shareholder value, but it’s actually about having access to capital to run our projects to achieve our passion,’ Tennyson said.Read More